Oversight on the borderline: Quality improvement and pragmatic research

Author:

Finkelstein Jonathan A1,Brickman Andrew L2,Capron Alexander3,Ford Daniel E4,Gombosev Adrijana5,Greene Sarah M6,Iafrate R Peter7,Kolaczkowski Laura8,Pallin Sarah C9,Pletcher Mark J10,Staman Karen L11,Vazquez Miguel A12,Sugarman Jeremy13

Affiliation:

1. Division of General Pediatrics, Boston Children’s Hospital, Departments of Pediatrics and Population Medicine, Harvard Medical School, Boston, MA, USA

2. Health Choice Network, Miami, FL, USA

3. Gould School of Law and Keck School of Medicine, University of Southern California, Los Angeles, CA, USA

4. Johns Hopkins School of Medicine, Baltimore, MD, USA

5. School of Medicine, University of California, Irvine, Irvine, CA, USA

6. Patient-Centered Outcomes Research Institute, Washington, DC, USA

7. University of Florida, Gainesville, FL, USA

8. Multiple Sclerosis Patient-Powered Research Network, University of Dayton, Dayton, OH, USA

9. Louisiana Public Health Institute, New Orleans, LA, USA

10. University of California, San Francisco, CA, USA

11. CHB Wordsmith, Inc., Raleigh, NC, USA

12. University of Texas Southwestern Medical Center, Dallas, TX, USA

13. Johns Hopkins Berman Institute of Bioethics, Baltimore, MD, USA

Abstract

Pragmatic research that compares interventions to improve the organization and delivery of health care may overlap, in both goals and methods, with quality improvement activities. When activities have attributes of both research and quality improvement, confusion often arises about what ethical oversight is, or should be, required. For routine quality improvement, in which the delivery of health care is modified in minor ways that create only minimal risks, oversight by local clinical or administrative leaders utilizing institutional policies may be sufficient. However, additional consideration should be given to activities that go beyond routine, local quality improvement to first determine whether such non-routine activities constitute research or quality improvement and, in either case, to ensure that independent oversight will occur. This should promote rigor, transparency, and protection of patients’ and clinicians’ rights, well-being, and privacy in all such activities. Specifically, we recommend that (1) health care organizations should have systematic policies and processes for designating activities as routine quality improvement, non-routine quality improvement, or quality improvement research and determining what oversight each will receive. (2) Health care organizations should have formal and explicit oversight processes for non-routine quality improvement activities that may include input from institutional quality improvement experts, health services researchers, administrators, clinicians, patient representatives, and those experienced in the ethics review of health care activities. (3) Quality improvement research requires review by an institutional review board; for such review to be effective, institutional review boards should develop particular expertise in assessing quality improvement research. (4) Stakeholders should be included in the review of non-routine quality improvement and quality improvement–related research proposals. Only by doing so will we optimally leverage both pragmatic research on health care delivery and local implementation through quality improvement as complementary activities for improving health.

Publisher

SAGE Publications

Subject

Pharmacology,General Medicine

Cited by 58 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3